BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16734733)

  • 1. Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan.
    Arisawa K; Soda M; Akahoshi M; Fujiwara S; Uemura H; Hiyoshi M; Takeda H; Kashino W; Suyama A
    Cancer Sci; 2006 Jun; 97(6):535-9. PubMed ID: 16734733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.
    Arisawa K; Soda M; Akahoshi M; Matsuo T; Nakashima E; Tomonaga M; Saito H
    Jpn J Cancer Res; 1998 Aug; 89(8):797-805. PubMed ID: 9765614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study.
    Arisawa K; Sobue T; Yoshimi I; Soda M; Shirahama S; Doi H; Katamine S; Saito H; Urata M
    Cancer Causes Control; 2003 Nov; 14(9):889-96. PubMed ID: 14682446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors: A cross-sectional study.
    Hida A; Imaizumi M; French B; Ohishi W; Haruta D; Eguchi K; Nakamura H; Kawakami A
    Medicine (Baltimore); 2021 Jun; 100(24):e26297. PubMed ID: 34128866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors.
    Matsuo T; Nakashima E; Carter RL; Neriishi K; Mabuchi K; Akiyama M; Shimaoka K; Kinoshita K; Tomonaga M; Ichimaru M
    J Radiat Res; 1995 Mar; 36(1):8-16. PubMed ID: 7616489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid cancer incidence in atomic bomb survivors: 1958-1998.
    Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
    Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan.
    Koga Y; Iwanaga M; Soda M; Inokuchi N; Sasaki D; Hasegawa H; Yanagihara K; Yamaguchi K; Kamihira S; Yamada Y
    J Med Virol; 2010 Apr; 82(4):668-74. PubMed ID: 20166187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.
    Arisaw K; Katamine S; Kamihira S; Kurokawa K; Sawada T; Soda M; Doi H; Saito H; Shirahama S
    Cancer Causes Control; 2002 Sep; 13(7):657-63. PubMed ID: 12296513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphotropic virus type 1 infection and gastric cancer development in Japan.
    Matsumoto S; Yamasaki K; Tsuji K; Shirahama S
    J Infect Dis; 2008 Jul; 198(1):10-5. PubMed ID: 18544011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality among inhabitants of an HTLV-I endemic area in Japan.
    Iwata K; Ito S; Saito H; Ito M; Nagatomo M; Yamasaki T; Yoshida S; Suto H; Tajima K
    Jpn J Cancer Res; 1994 Mar; 85(3):231-7. PubMed ID: 8188520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
    Imaizumi M; Usa T; Tominaga T; Neriishi K; Akahoshi M; Nakashima E; Ashizawa K; Hida A; Soda M; Fujiwara S; Yamada M; Ejima E; Yokoyama N; Okubo M; Sugino K; Suzuki G; Maeda R; Nagataki S; Eguchi K
    JAMA; 2006 Mar; 295(9):1011-22. PubMed ID: 16507802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic distribution of the incidence of adult T-cell leukemia/lymphoma and other malignancies in nagasaki prefecture, Japan.
    Arisawa K; Soda M; Shirahama S; Saito H; Takamura N; Yamaguchi M; Odagiri K; Nakagoe T; Suyama A; Doi H
    Jpn J Clin Oncol; 2002 Aug; 32(8):301-6. PubMed ID: 12411568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.
    Boschi-Pinto C; Stuver S; Okayama A; Trichopoulos D; Orav EJ; Tsubouchi H; Mueller N
    J Infect Dis; 2000 Jan; 181(1):35-41. PubMed ID: 10608748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of multiple primary cancers in Nagasaki atomic bomb survivors: association with radiation exposure.
    Nakashima M; Kondo H; Miura S; Soda M; Hayashi T; Matsuo T; Yamashita S; Sekine I
    Cancer Sci; 2008 Jan; 99(1):87-92. PubMed ID: 17979995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer.
    Hirata T; Nakamoto M; Nakamura M; Kinjo N; Hokama A; Kinjo F; Fujita J
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2238-41. PubMed ID: 18031387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Period prevalence of uveitis in human T-lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands Study.
    Miyata J; Yamanashi H; Dake Y; Nobusue K; Doi Y; Honda Y; Nonaka F; Arima K; Tamai M; Sasaki D; Shimizu Y; Hasegawa H; Kitaoka T; Yanagihara K; Aoyagi K; Kawakami A; Maeda T
    J Med Virol; 2024 May; 96(5):e29653. PubMed ID: 38712746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.
    Santos RF; Conceição GC; Martins MS; Kraychete A; Penalva MA; Carvalho EM; Lopes AA; Rocha PN
    BMC Nephrol; 2017 Feb; 18(1):64. PubMed ID: 28202003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
    Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.